ArticleFrontiers in neurology2025
Analysis of risk factors for poor prognosis after endovascular treatment of tandem lesions in acute ischemic stroke.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Systemic immune-inflammation index predicts hemorrhagic transformation after endovascular therapy for ischemic stroke.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims/background: In China, the incidence of acute ischemic stroke (AIS) has been rising annually, accounting for 60-70% of all stroke cases. To explore the risk factors leading to poor prognosis after endovascular treatment in patients with acute ischemic stroke tandem lesions after endovascular treatment. Methods: A retrospective analysis was conducted on the clinical data of patients with tandem lesions who underwent endovascular therapy at Jiangyin People's Hospital affiliated with Xuzhou Medical University, from July 2018 to August 2023. Post-treatment revascularization was assessed using the modified Thrombolysis in Cerebral Infarction (mTICI) grading system, with grades 3 and 2b indicating good recanalization and grades 2a and below indicating poor recanalization. Patient prognosis at 90 days post-procedure was evaluated using the modified Rankin Scale (mRS), with scores of 0-2 classified as good prognosis and 3-6 as poor prognosis. The age, admission National Institutes of Health Stroke Scale score (NIHSS), gender, hypertension, diabetes mellitus, coronary artery disease, smoking, atrial fibrillation, carotid artery stenting, revascularization, site of tandem lesion (anterior or posterior circulation), and onset-recanalization time (minutes) of the enrolled patients were subjected to univariate analysis. Univariate analysis was performed, followed by multivariate logistic regression for variables with Results: A total of 75 patients were included, of whom 32 had good 90-day outcomes and 43 had poor outcomes. Compared to the good outcome group, patients with poor outcomes were older, had higher NIHSS scores at admission, and were less likely to achieve good recanalization (all Conclusion: Advanced age, elevated NIHSS score on admission, and suboptimal recanalization are independently associated with poor 90-day outcomes following endovascular treatment for tandem lesions. The NIHSS score may aid in early risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.